Retrovirology (Sep 2012)

rAd5/NYVAC-B is superior to NYVAC-B/rAd5 and is dependent on rAd5 dose for neutralizing antibody responses against HIV-1

  • Montefiori DC,
  • Huang Y,
  • Karuna S,
  • Allen M,
  • Kochar N,
  • Chappuis S,
  • Gaillard J,
  • Tomaras G,
  • Graham B,
  • Bart P,
  • Pantaleo G

DOI
https://doi.org/10.1186/1742-4690-9-S2-P132
Journal volume & issue
Vol. 9, no. Suppl 2
p. P132

Abstract

Read online

No abstracts available.